Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shoulder Innovations, Inc. ( (SI) ) just unveiled an announcement.
Shoulder Innovations reported that 2025 was a transformational year, with net revenue rising 50% to $47.3 million on strong adoption of its implant systems and a 61% increase in core and contender surgeons, despite a wider full-year net loss of $40.4 million driven by higher operating expenses and valuation-related charges. For the fourth quarter ended December 31, 2025, revenue grew 65% to $14.4 million with gross margins holding above 76%, while the company invested heavily in R&D, launched new humeral stem and metal-sensitive humeral head products, formed a robotic shoulder arthroplasty partnership, added former Inari Medical CEO Drew Hykes to its board, issued 2026 revenue guidance of $62–$65 million, and disclosed that director Michael Carusi will not stand for re-election at the 2026 annual meeting, though his departure is not tied to any disagreement with management.
The most recent analyst rating on (SI) stock is a Sell with a $12.50 price target. To see the full list of analyst forecasts on Shoulder Innovations, Inc. stock, see the SI Stock Forecast page.
Spark’s Take on SI Stock
According to Spark, TipRanks’ AI Analyst, SI is a Neutral.
The overall stock score is primarily influenced by financial performance challenges, including profitability and cash flow issues. However, positive technical indicators and a strategic partnership provide some optimism. The valuation remains a concern due to negative earnings, but the corporate event could improve future prospects.
To see Spark’s full report on SI stock, click here.
More about Shoulder Innovations, Inc.
Shoulder Innovations, Inc. is a commercial-stage medical technology company focused exclusively on transforming the shoulder surgical care market. The company develops and commercializes advanced shoulder implant systems and enabling technologies, targeting orthopedic surgeons and hospitals seeking specialized solutions for shoulder arthroplasty and related procedures.
Average Trading Volume: 55,178
Technical Sentiment Signal: Strong Sell
Current Market Cap: $275.9M
For detailed information about SI stock, go to TipRanks’ Stock Analysis page.